Handelsbanken Fonder AB - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$10
-67.7%
13,9340.0%0.00%
Q4 2022$31
-99.9%
13,9340.0%0.00%
Q3 2022$45,000
-15.1%
13,9340.0%0.00%
Q2 2022$53,000
-71.5%
13,934
-59.7%
0.00%
-100.0%
Q1 2022$186,000
-60.2%
34,5340.0%0.00%
-50.0%
Q4 2021$467,000
-24.7%
34,5340.0%0.00%
-33.3%
Q3 2021$620,000
+4.6%
34,5340.0%0.00%0.0%
Q2 2021$593,000
-14.2%
34,5340.0%0.00%
-25.0%
Q1 2021$691,000
+17.7%
34,5340.0%0.00%0.0%
Q4 2020$587,000
+2.4%
34,5340.0%0.00%0.0%
Q3 2020$573,000
-64.2%
34,534
-50.0%
0.00%
-42.9%
Q2 2020$1,600,000
-23.8%
69,068
+17.0%
0.01%
-82.1%
Q2 2019$2,100,000
-16.9%
59,033
-21.5%
0.04%
-20.4%
Q1 2019$2,528,000
+20.1%
75,233
+17.5%
0.05%
+16.7%
Q4 2018$2,105,000
-31.6%
64,033
+26.8%
0.04%
+10.5%
Q3 2018$3,078,000
+106.7%
50,500
+65.6%
0.04%
+31.0%
Q2 2018$1,489,000
-85.4%
30,500
-68.2%
0.03%
-72.6%
Q1 2018$10,200,000
+147.5%
96,000
+39.1%
0.11%
+116.3%
Q4 2017$4,121,00069,0000.05%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders